Cargando…
Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells
BACKGROUND: Gene therapy using a recombinant adenovirus (Ad) encoding secretory human endostatin (Ad-Endo) has been demonstrated to be a promising antiangiogenesis and antitumor strategy of in animal models and clinical trials. The E1B55KD-deficient Ad dl1520 was also found to replicate selectively...
Autores principales: | Li, Li-xia, Zhang, Yan-ling, Zhou, Ling, Ke, Miao-la, Chen, Jie-min, Fu, Xiang, Ye, Chun-ling, Wu, Jiang-xue, Liu, Ran-yi, Huang, Wenlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853970/ https://www.ncbi.nlm.nih.gov/pubmed/24124726 http://dx.doi.org/10.1186/1479-5876-11-257 |
Ejemplares similares
-
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
por: Watanabe, Maki, et al.
Publicado: (2021) -
Generation and Characterization of a Replication-Competent Human Adenovirus Type 55 Encoding EGFP
por: Li, Wei, et al.
Publicado: (2023) -
Gene therapy for bladder cancer using E1B-55 kD-deleted adenovirus in combination with adenoviral vector encoding plasminogen kringles 1–5
por: Hsieh, J-L, et al.
Publicado: (2003) -
E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases
por: Zhao, Peng, et al.
Publicado: (2010) -
Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009–2012
por: Lu, Qing-Bin, et al.
Publicado: (2014)